NCT03303066 Efficacy and Safety of FG-4592 for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome (MDS) Status COMPLETED Phase PHASE2/PHASE3
NCT03302884 Circulating Tumor DNA as an Early Marker of Recurrence and Treatment Efficacy in Ovarian Carcinoma Status UNKNOWN Phase NA
NCT03298451 Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03297606 Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR) Status RECRUITING Phase PHASE2
NCT03290287 Aclidinium Bromide Post-Authorisation Safety Study to Evaluate the Risk of Cardiovascular Endpoints Status COMPLETED Phase N/A
NCT03290014 Sleep Quality in (COPD) Patients (COPD: Chronic Obstructive Pulmonary Disease) Status UNKNOWN Phase N/A
NCT03286842 To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients. Status COMPLETED Phase PHASE3
NCT03283605 Immunotherapy and SBRT for Metastatic Head and Neck Carcinomas Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03283267 A Safety and Pharmacodynamic Study of Healthy Chinese Subjects Administered Sodium Zirconium Cyclosilicate (ZS) Status COMPLETED Phase PHASE1
NCT03277482 Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer Status TERMINATED Phase PHASE1
NCT03276078 Pharmacokinetics, Safety and Tolerability of Twice-Daily Aclidinium Bromide/Formoterol Fumarate Fixed Dose Combination in Chinese Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease Status COMPLETED Phase PHASE2
NCT03276052 A Phase I, Open-Label, Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Aclidinium Bromide in Healthy Chinese Participants Status COMPLETED Phase PHASE1
NCT03275922 Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE Status COMPLETED Phase PHASE3
NCT03275597 Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Non-small Lung Cancer (NSCLC) With Dual Immune Checkpoint Inhibition Status TERMINATED Phase PHASE1
NCT03275311 Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008 Status RECRUITING Phase N/A
NCT03275116 The Effect of Twice Daily vs. Once Daily Bronchodilation on Hyperinflation in COPD Patients During 24 Hours. Status UNKNOWN Phase PHASE4